Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides fluid management services; biolayer interferometry instruments; microbiology testing, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; screening instruments; biomolecule analysis tools; batch liquid chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; water purification systems; and weighing products. In addition, the company offers data analytics software; process automation platform and software; and transfection reagents and plasmid DNA solutions. The company has a collaboration with Bio Usawa Biotechnology, Ltd. focusing on developing and manufacturing monoclonal antibodies in Sub-Saharan Africa to tackle oncology, diabetes-induced eye diseases, infectious diseases, and autoimmune conditions. It serves manufacturers of medications, vaccines, food, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.
Frequently asked questions
What sector does Sartorius Stedim Biotech S.A (SDMHF) operate in?
Sartorius Stedim Biotech S.A belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is Sartorius Stedim Biotech S.A (SDMHF) current stock price?
As of the latest data, Sartorius Stedim Biotech S.A stock price is $239.00, with a previous close of $239.00.
What is Sartorius Stedim Biotech S.A (SDMHF) current market capitalization?
Sartorius Stedim Biotech S.A market cap is approximately 23.25 billion.
What is Sartorius Stedim Biotech S.A (SDMHF) Earnings Per Share (EPS)?
The trailing EPS is $3.87.
What is Sartorius Stedim Biotech S.A (SDMHF) Price-to-Earnings (P/E) ratio?
Sartorius Stedim Biotech S.A current P/E ratio is 61.76.
What is Sartorius Stedim Biotech S.A (SDMHF) EBITDA?
Sartorius Stedim Biotech S.A EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 226.88 million.
Does Sartorius Stedim Biotech S.A (SDMHF) pay dividends?
Yes. Sartorius Stedim Biotech S.A pays annual dividends with an annualized yield of 0.34% and an estimated annual payout of $0.81 per share.
When is the next ex-dividend date for Sartorius Stedim Biotech S.A (SDMHF)?
The next ex-dividend date is scheduled for April 01, 2027.
When is Sartorius Stedim Biotech S.A (SDMHF) next earnings report?
Sartorius Stedim Biotech S.A is expected to release its next earnings report on September 30, 2026.
What is Sartorius Stedim Biotech S.A (SDMHF) beta (volatility) score?
Sartorius Stedim Biotech S.A has a beta of 1.105, meaning its volatility is roughly in line with the market.
